NewsRx

Search our medical news database

Endologix, Inc.

Endologix Reports 36% Revenue Growth in 2008

Published in Healthcare Mergers, Acquisitions and Ventures Week, March 7th, 2009

Endologix, Inc. (Nasdaq: ELGX), developer and manufacturer of the Powerlink® endovascular stent graft for the minimally invasive treatment of abdominal aortic aneurysms (AAA), announced financial results for the three months and 12 months ended December 31, 2008.

“We had a strong finish to 2008, reporting record revenue for the fourth quarter. Domestic product revenue grew 35% compared with the 2007 fourth quarter and reflected initial sales from our suprarenal proximal extensions and Powerlink XL® introduced late last year. Feedback regarding these new products has been very positive,” said John McDermott, Endologix President and Chief Executive Officer. “We exceeded...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook